Published in the journal, Lancet Neurology, a new study suggests that understanding stroke severity, as well as time to treatment, is key to delivering effective and safe thrombolysis treatment.
On February 11 2015, at the International Stroke Conference (ISC 2015 in Nashville, USA) the latest findings were released from four, large studies investigating the effect of treating patients with mechanical clo
This research will produce an assessment of functional, everyday reading. The assessment will help therapists working with people with aphasia to identify why the person is finding it difficult to read and monitor the effects of treatment.
This study will show whether more intensive lowering of blood pressure (BP) in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury. If successful, the study will pave the way for the design a larger definitive trial.
In this study, we are testing the theory that by treating BP more intensively we will delay progression of the disease. We will also use state-of-the-art MRI imaging techniques to look at the mechanisms by which any beneficial effect of BP occurs.
We anticipate a shortfall of £1.5 million in our funding programme this year to resume current research and support vital new projects. This could have a catastrophic knock-on effect for stroke research and delay access to important new life-changing treatments that allow people to rebuild their lives after stroke.
Vision problems are common after stroke. This Lectureship will investigate the link between the tasks used in vision rehabilitation and everyday visual activities. It will also use brain scanning to investigate the effects of rehabilitation on activity in the areas of the brain responsible for vision.
Co-funded by the Stroke Association, a new review of the research into NIBS (non-invasive brain stimulation) for the recovery of leg movement and walking suggests that although it can bring about changes in leg function, the design of existing studies are very different, making it difficult to determine its effectiveness.
Visual field loss is a commonly reported side effect of stroke and can seriously impact on functional ability and quality of life. Published today in the journal, Neuro-Ophthalmology, a new study shares insights learned from the recruitment of study participants to the 'VISION' trial, and how this may inform future, similar trials.
The International Stroke Conference (ISC) is the world's largest meeting dedicated to the science and treatment of stroke and its effects. Watch the highlights summary video from the ISC Programme Committee, and find out about the result of the international HeadPoST trial, and take-homes from our International Development Officer, Sarah Belson.